Bio-Rad Laboratories Inc (BIO)
Current ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 1,207,100 | 3,048,330 | 3,157,980 | 1,989,090 | 2,139,840 |
| Total current liabilities | US$ in thousands | 467,800 | 522,799 | 568,708 | 680,938 | 631,536 |
| Current ratio | 2.58 | 5.83 | 5.55 | 2.92 | 3.39 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $1,207,100K ÷ $467,800K
= 2.58
The current ratio of Bio-Rad Laboratories Inc has shown fluctuations over the past five years. In December 31, 2020, the current ratio was 3.39, indicating a healthy level of liquidity to cover short-term obligations. However, by December 31, 2021, the ratio decreased to 2.92, which suggests a slight decrease in liquidity.
Over the next two years, the current ratio significantly improved, reaching 5.55 by December 31, 2022 and further increasing to 5.83 by December 31, 2023. These ratios indicate a substantial improvement in the company's short-term liquidity position, reflecting a stronger ability to meet current liabilities with current assets.
However, by December 31, 2024, the current ratio decreased to 2.58, which may raise concerns about the company's liquidity position. A lower current ratio could imply potential difficulties in meeting short-term obligations without relying on external financing.
Overall, while the current ratio of Bio-Rad Laboratories Inc has shown some fluctuations, it is essential for stakeholders to monitor this ratio closely to assess the company's ability to manage short-term financial obligations effectively.
Peer comparison
Dec 31, 2024